Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Subendometrial growth hormone injection for frozen embryo transfer in recurrent implantation failure
IRCT20091012002576N30Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Sep 2023
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, single-blind, single-arm trial of somatropin in infertility and Recurrent Implantation Failure (RIF), sponsored by Tehran University of Medical Sciences. Primary endpoints: Chemical pregnancy and Clinical pregnancy. Started Sep 2023; status: completed.
02
Drugs
somatropin
03
Conditions
infertilityRecurrent Implantation Failure (RIF)
Beyond the preview
Go deeper on IRCT20091012002576N30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20091012002576N30.